This website uses cookies to ensure you get the best experience. Learn more ...
Morning Overview on MSN
FDA to fast-track reviews of 3 psychedelic drugs after Trump directive
The FDA will put three psychedelic drug programs on an ultra-fast approval track, compressing review timelines from roughly 10 to 12 months to as little as one to two months. The agency announced in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results